Загрузка...
A Diverse Panel of Hepatitis C Virus Glycoproteins for Use in Vaccine Research Reveals Extremes of Monoclonal Antibody Neutralization Resistance
Despite significant advances in the treatment of hepatitis C virus (HCV) infection, the need to develop preventative vaccines remains. Identification of the best vaccine candidates and evaluation of their performance in preclinical and clinical development will require appropriate neutralization ass...
Сохранить в:
| Опубликовано в: : | J Virol |
|---|---|
| Главные авторы: | , , , , , , , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
American Society for Microbiology
2016
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4794667/ https://ncbi.nlm.nih.gov/pubmed/26699643 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/JVI.02700-15 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|